91ÁÔĆć

College News

UHCOP ASHP 2025 Poster Presentation Count

Top Tier at Midyear

ASHP Mid-year Research Poster Count Ranks #1 in Texas, #4 in Nation

Dec. 4 — 91ÁÔĆć College of Pharmacy Pharm.D. students will be presenting the highest number of research posters in Texas — and fourth highest in the nation — among their pharmacy school peers at the 2025 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exposition Dec. 7-10 in Las Vegas, Nev.

Forty-one research posters by UHCOP students were accepted for presentation at the ASHP meeting.

The presenting student authors and their project titles are: 

  • Shahad Alfartosy, “Evaluating the Safety of Non-Provider Order Entry for High-Risk Medications”;
  • Julia Arriazola, “Real-World Utilization and Clinical Outcomes of Digoxin Immune Fab in an Academic County Health System”;
  • Romafou Bates, “Assessing and Recommending the Cost-Effective Management of Neuromyelitis Optica Spectrum Disorders at Our Institution”;
  • Victoria Briggs, “Evaluation of Impella Anticoagulation Strategies on Thromboembolic and Bleeding Complications”;
  • Andy Dang, “Evaluation of Clinical and Safety Outcomes with Weight-Based Versus Fixed-Dose Four-Factor Prothrombin Complex Concentrate for the Reversal of Warfarin-Related Bleeding at an Academic County Health-System”;
  • Atefeh Ghane Ezabadi, “IDSA Guidelines on UTI Management: A Comparative Review of Evolving Recommendations for Clinician Education”;
  • Estrella Flores, “Identifying Opportunities to Optimize Sulfonylurea Therapy in Adults ≥65 Years with Type 2 Diabetes at a Large Federally Qualified Health Center”;
  • Megan Huang Frazier, “Evaluation of an Institutional Protocol for Anticoagulation Management After HeartMate 3 LVAD Implantation”;
  • Glory Garcia, “Evaluating Renal Monitoring Practices for Tenofovir Disoproxil Fumarate-Based Therapies for Patients Living with HIV and Hepatitis B at a Large Federally Qualified Health Center”;
  • Gabriela Gaytán, “Semaglutide Use in a Patient with a Long-Term Ileostomy: A Case Report Highlighting Clinical Risks and Evidence Gaps”;
  • Arshia Ghaneian, “Analyzing Cabotegravir Prior Authorization Denials: A Retrospective Review of Payor and Denial Reasons in 2024 – 2025”;
  • Alyssa Glass, “Evaluation of Early Versus Delayed Tacrolimus Initiation Post Kidney Transplantation”;
  • Victoria Hellner, “Evaluation of Overnight Meropenem Use at a Free-Standing Children’s Hospital”;
  • Madeline Hogan, “Evaluation of Amiodarone Loading Doses at a Large Academic Medical Center”;
  • Braxton Jones, “Evaluation of Electrolyte Monitoring After Denosumab Administration in Advanced Chronic Kidney Disease”;
  • Sharmane Joubert, “Wake Up and Breathe: Coordination of Spontaneous Awakening Trials and Spontaneous Breathing Trials in the Medical Intensive Care Unit”;
  • Gowri Kalyani, “Evaluation of 7-Day vs. Prolonged Antibiotic Therapy for Pyelonephritis”;
  • John-Han Le, “Pharmacist Telehealth-Led Interventions for Optimizing Heart Failure Care: A Systematic Review”;
  • Susan Le, “Evaluation of Nebulized Mucolytic Therapy in Hospitalized Patients”;
  • Grace Liu, “Opioid and Benzodiazepine Stewardship in a Large Academic Medical Center”;
  • Cynthia Ma, “Impact of Clotrimazole on Tacrolimus Level in Kidney Transplant Patients”;
  • Jasmine Malhotra, “Exploration of the Impact of Clostridioides difficile Infection on Gut Translocation Events: A Pilot Study”;
  • Annie Man, “Medication Use Evaluation of Anakinra in the Pediatric Intensive Care Unit at a Tertiary Academic Medical Center”;
  • Veronica Mares, “Assessment of Antimicrobial Waste at a Children’s Hospital”;
  • Sydney Mohr, “Impact of Acute Kidney Injury in Cardiac Surgery Patients at a Large Academic Medical Center”;
  • Ariana Moorer, “Descriptive Analysis of Kidney Transplant Recipients Diagnosed with New Onset Atypical Hemolytic Uremic Syndrome Post-Transplant”;
  • Harris Nguyen, “Impact of Pre-Operative Antibiotic Timing Relative to First Surgical Incision on Pocket Site Infections”;
  • Ogechi Ngwakwe, “Alcohol Use Disorder in Patients with  Gambling Addiction: Prevalence and Associated Risk Factors”;
  • Anh Pham, “A Systematic Review of the Impact of Glucagon-Like Peptide-1 Agonists on Insomnia”;
  • Lyna Pham, “Evaluation of Zolpidem Utilization in the Hospital Setting Among Older Adults Following Implementation of a Hard-Stop Therapeutic Interchange Clinical Decision Support (CDS)”;
  • Kathryn Preston, “Trimethoprim-Sulfamethoxazole for the treatment of Stenotrophomonas maltophilia in the Pediatric Intensive Care Unit”;
  • Dewan Protiva, “Management of Patients with Sickle Cell Disease (SCD) and Group 5 Pulmonary Hypertension (PH): A Systematic Review”;
  • Noemie Senawong, “Reducing Readmission Risk Through Guideline-Concordant Care in Atrial Fibrillation”;
  • Maliha Sultana, “Evaluation of Patient-Reported Outcomes Using Hidradenitis Suppurative Quality of Life Surveys to Support Patient Management in an Outpatient Clinical Setting”;
  • Brandy Tran, “An Evaluation of the Efficacy and Safety of Anticoagulation Therapy in Peripartum Cardiomyopathy Patients: A Systematic Review”;
  • Gia Tran, “Evaluation of System-Wide Pharmacy Interventions to Reduce Nighttime Medication Administrations and Sleep Disruption Among Hospitalized Patients”;
  • Aniqa Virani, “Isavuconazonium Sulfate Medication Utilization Evaluation”;
  • Alice Vu, “Diagnostic and Therapeutic Gaps in Suspected Hemophagocytic Lymphohistiocytosis Among Adult Leukemia Patients: A Retrospective Single Center Study”;
  • Brittany Vuong, “Evaluating Nursing Compliance with an Integrated Heparin Calculator in the Medication Administration Record (MAR)”;
  • Robert Williams, “Workflow and Productivity Optimization: A Direct Time-Study”; and
  • Dana Yun, “Evaluating the Impact of Pharmacy-Led Admission Medication Reconciliation on Patient Outcomes Across a Multi-Campus Health System.”